Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Eugenia
Eugenia Carrillo Gallego, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20110086369 | FLUORESCENT COMPOUNDS FOR THE DIAGNOSIS OF INFECTIONS, PRODUCTION METHOD, AND APPLICATIONS THEREOF - The present invention describes novel fluorescent compounds analogous to alkyl phospholipids, containing highly photostable fluorescent groups in the structure thereof and emitting in the visible spectrum wavelength zone. Said compounds are easily introduced to microorganisms, enabling the detection and identification of these organisms by means of fluorescence microscopy. The novel fluorescent compounds can also diagnose, rapidly and easily, the presence of pathogenic microorganisms characterised in that they are resistant to treatment with alkyl phospholipids. | 04-14-2011 |
Eugenia Corrales, Los Altos Hills, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100043864 | Optical Support Apparatus - The present invention provides an apparatus for mounting an optical element on the underside of a substrate in a solar energy system, as a replacement for, or supplemental support to, an adhesive. The apparatus includes one or more support arms which uphold the optical element. The support arms may be secured in place by being coupled to various components of the solar energy system, such as a front panel, an enclosure, or a primary mirror. | 02-25-2010 |
Eugenia Gruzglin, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100310451 | ALTERED N-CADHERIN PROCESSING IN TUMOR CELLS BY FURIN AND PROPROTEIN CONVERTASE 5A (PC5A) - The present invention relates to a method for diagnosis and/or prognosis of cancer and for monitoring the progression of cancer and/or the therapeutic efficacy of an anti-cancer treatment in a subject by determining the molecular form of cadherin at the cell surface of cancer cells in the subject. The invention also relates to a method for preventing, inhibiting or treating cancer or its metastasis in a subject by increasing the adhesive forms of cadherin and/or decreasing the non-adhesive forms of cadherin at the cell surface. The invention also relates to a method step of determining the expression level of furin and proprotein convertase 5A (PC5A). | 12-09-2010 |
Eugenia Kumacheva, Toronto CA
| Patent application number | Description | Published |
|---|---|---|
| 20100172803 | METHOD AND APPARATUS FOR FLUID DISPERSION - A microfluidic method and device for focusing and/or forming discontinuous sections of similar or dissimilar size in a fluid is provided. The device can be fabricated simply from readily-available, inexpensive material using simple techniques. | 07-08-2010 |
| 20100184928 | MULTIPLE CONTINUOUS MICROFLUIDIC REACTORS FOR THE SCALED UP SYNTHESIS OF GEL OR POLYMER PARTICLES - This present invention provides devices for the parallelization of the formation of droplets in a multiple droplet generator integrating two or more parallel flow-focusing devices (FFDs) with either identical, or different, geometries. In the parallel identical FFDs, emulsification generates droplets with a narrow (below 4%) polydispersity despite weak coupling between the identical flow-focusing devices. Formation of droplets in the integrated droplet generator comprising FFDs with different dimensions of the microchannels occurs with strong coupling between the FFDs and produces droplets with varying sizes and size distributions. For such devices the regime in which emulsification produces droplets with varying dimensions and a narrow size distribution have been identified. The results of this work can be used in scaling up the production of droplets and in the simultaneous production of droplets and particles with different dimensions. | 07-22-2010 |
| 20110129941 | Method of Producing Polymeric Particles With Selected Size, Shape, Morphology and Composition - The present invention provides a method and apparatus for producing polymeric particles with pre-designed size, shape, morphology and composition, and more particularly the present invention uses a microfluidic polymerization reactor for producing same. The present invention disclosed herein provides a process for producing polymer particles with pre-selected shapes. The method includes injecting a first fluid comprising a polymerizable constituent with a controlled flow rate into a microfluidic channel and injecting a second fluid with a controlled flow rate into the microfluidic channel in which the second fluid mixes with the first fluid, the second fluid being immiscible with the first fluid so that the first fluid forms into droplets in the microfluidic channel. The microfluidic channel has pre-selected dimensions to give droplets of pre-selected size, morphology and shape. The microfluidic channel is sufficiently long so that the droplets have a sufficiently long residence time in the channel so that they polymerize or otherwise harden into droplets of pre-selected size and shape. | 06-02-2011 |
| 20110140030 | METHOD OF PRODUCING HYBRID POLYMER-INORGANIC MATERIALS - Hybrid composite materials with multiscale morphologies are formed by doping polymer submicrometer spheres with semiconductor or metal (e.g. CdS or Ag, respectively) nanoparticles and using these doped microspheres as functional building blocks in production of hybrid periodically structured materials. The preparation of hybrid polymer particles include the following stages: (i) synthesis of monodisperse polymer microspheres, (ii) in-situ synthesis of the inorganic nanoparticles either on the surface, or in the bulk with polymer beads, and (iii) encapsulation of hybrid microspheres with a hydrophobic shell. | 06-16-2011 |
Eugenia Lubashevsky, Bneiy Aish IL
| Patent application number | Description | Published |
|---|---|---|
| 20090186111 | Novel Bacteria and Pharmaceutically Active Products Obtained Therefrom - A substance obtainable from | 07-23-2009 |
Eugenia Migliavacca, Lausanne CH
| Patent application number | Description | Published |
|---|---|---|
| 20110076283 | METHOD FOR PREDICTING AND DIAGNOSING BRAIN TUMOR - The present invention relates to a method for predicting or diagnosing outcome of concomitant chemo-radiotherapy of a subject suffering from brain tumor. The present invention further relates to compositions and methods for treatment or prevention of tumor resistance in a subject suffering from a brain tumor and to a kit useful for predicting or diagnosing the tumor resistance in a subject treated with concomitant chemo-radiotherapy. | 03-31-2011 |
Eugenia Oton Sanchez, Hambourg DE
| Patent application number | Description | Published |
|---|---|---|
| 20100143545 | MOUSSE - The present invention provides a shelf-stable mousse comprising an aerated oil-in-water emulsion characterised in that the mousse has a storage modulus at 20° C. of less than 50,000 Pa. It also provides a process to prepare said mousse. | 06-10-2010 |
Eugenia Pasca, Woodinville, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20090195875 | Avoiding Interference Artifacts in a Head-Up Display or a Reflected See-Through Type Display - Briefly, in accordance with one or more embodiments, a birefringent layer may be utilized in conjunction with a head-up display (HUD) for a vehicle or the like, for example where the birefringent layer is disposed in or on the windshield. The birefringent layer may impart a change in the polarization of light emerging from a projector of the head-up display in order to reduce or minimize interference between beams from the display and reflecting off of two or more surfaces that are combined at the viewer's eye, and/or to reduce or minimize the effect of polarizing sunglasses on the viewability of the image projected by the display. In one or more embodiments, the birefringent layer alters the polarization of the light reaching the viewer's eye if the user is wearing polarizing glasses or lenses so that less light from the display is blocked. | 08-06-2009 |
Eugenia Rodriguez Sierra, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100272843 | ULTRASONIC DEVICE FOR MOULDING MICRO PLASTIC PARTS - The invention relates to an ultrasonic device for molding micro plastic parts, which combines: a) a mold cavity configured in a mold having an inlet for supplying plastic material to a chamber with an access opening and the chamber facing the cavity at a distal end in relation to its access opening; b) a cantilevered ultrasonic vibration element associated with an ultrasound generator, with an end portion or tip inserted tightly into the chamber through the access opening in an axially centered manner; c) a movement device for generating a relative movement between the end portion and the parts of the mold so that the end portion engages with the supplied plastic material and exerts a pressure of pre-determined magnitude thereon upon activation of the ultrasonic vibration element. | 10-28-2010 |
Eugenia Wang, Prospect, KY US
| Patent application number | Description | Published |
|---|---|---|
| 20080233561 | Method for Measuring Cytopathic Effect Due to Viral Infection in Cells Using Electric Cell-Substrate Impedance Sensing - A method of measuring cytopathic effect in cells includes providing cells in culture, using electric cell-substrate impedance sensing (ECIS) to measure the resistance of current associated with the cells, and quantifying the cytopathic effect (CPE) associated with the cells based on the measured resistance. The cells may be identified as being infected with a virus if the CPE associated with the cells is above a predetermined level. Alternatively, the cells may be provided in a healthy monolayer and infected with a virus in order to measure the effect of the virus on CPE associated with the cells. Cells may also be treated with candidate antiviral agents and the effects of the agents on the virus-infected cells may be measured to screen for and identify actual antiviral agents. | 09-25-2008 |
| 20080312099 | Microarray, System, and Method for Detecting, Identifying, and Quantitating Micro-Rnas - Micro-RNA (miRNA) microarrays useful for detecting, identifying and quantitating miRNAs in a sample include oligonucleotide probes that specifically bind miRNAs. Exemplary miRNA microarray can be specific for miRNAs of human, canine, mouse, rat, or another species. | 12-18-2008 |
| 20090035331 | Systems and Methods for Targeted and Controlled Delivery of Agents - An Agent Delivery System allows for targeted and controlled delivery of an agent or agents to target site, such as specific cells or a specific tissue of an individual. An exemplary Agent Delivery System includes a platform, having a silica crystal lattice base plate, coated with a collagen-containing layer. At least one agent of interest is disposed within the platform, for delivering to the target site. The agent is released when the Agent Delivery Platform is exposed to collagen-degrading compounds. Collagen-degrading compounds can be secreted by cells within a target site. | 02-05-2009 |